| Tami Jessica Bang, MD | |
|
12605 E 16th Ave, Aurora, CO 80045-2545 | |
| (720) 848-0000 | |
| Not Available |
| Full Name | Tami Jessica Bang |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 14 Years |
| Location | 12605 E 16th Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851612204 | NPI | - | NPPES |
| 63430771 | Medicaid | CO |
| Facility Name | Location | Facility Type |
|---|---|---|
| National Jewish Health | Denver, CO | Hospital |
| University Of Colorado Hospital Authority | Aurora, CO | Hospital |
| Saint Joseph Hospital | Denver, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| National Jewish Health | 4587577028 | 220 |
News Archive
The fight against fake medicines could soon be aided by a small, portable device that quickly measures the hardness of a tablet, revealing whether it is counterfeit, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.
Brazilian researchers aim to determine the emergence and spread of the Delta VOC in different regions in Brazil.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information regarding a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection in elderly patients with acute myeloid leukemia (AML). The comparator in this trial was low-dose cytarabine, a chemotherapy agent, or supportive care.
Earlier today, Anthem Blue Cross agreed to a request by the California Department of Insurance to postpone a rate adjustment for individual members in California by two months to allow the Department additional time for review. To avoid confusion for our members, this delay will impact all Anthem individual members regulated at either the state Department of Insurance or the Department of Managed Health Care.
› Verified 9 days ago
| Entity Name | National Jewish Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326015777 PECOS PAC ID: 4587577028 Enrollment ID: O20031110000757 |
News Archive
The fight against fake medicines could soon be aided by a small, portable device that quickly measures the hardness of a tablet, revealing whether it is counterfeit, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.
Brazilian researchers aim to determine the emergence and spread of the Delta VOC in different regions in Brazil.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information regarding a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection in elderly patients with acute myeloid leukemia (AML). The comparator in this trial was low-dose cytarabine, a chemotherapy agent, or supportive care.
Earlier today, Anthem Blue Cross agreed to a request by the California Department of Insurance to postpone a rate adjustment for individual members in California by two months to allow the Department additional time for review. To avoid confusion for our members, this delay will impact all Anthem individual members regulated at either the state Department of Insurance or the Department of Managed Health Care.
› Verified 9 days ago
| Entity Name | Uchealth Imaging Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396210902 PECOS PAC ID: 5799021291 Enrollment ID: O20190103002022 |
News Archive
The fight against fake medicines could soon be aided by a small, portable device that quickly measures the hardness of a tablet, revealing whether it is counterfeit, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.
Brazilian researchers aim to determine the emergence and spread of the Delta VOC in different regions in Brazil.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information regarding a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection in elderly patients with acute myeloid leukemia (AML). The comparator in this trial was low-dose cytarabine, a chemotherapy agent, or supportive care.
Earlier today, Anthem Blue Cross agreed to a request by the California Department of Insurance to postpone a rate adjustment for individual members in California by two months to allow the Department additional time for review. To avoid confusion for our members, this delay will impact all Anthem individual members regulated at either the state Department of Insurance or the Department of Managed Health Care.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tami Jessica Bang, MD 1400 Jackson St, Graduate Medical Education Program, Denver, CO 80206-2761 Ph: (303) 388-4461 | Tami Jessica Bang, MD 12605 E 16th Ave, Aurora, CO 80045-2545 Ph: (720) 848-0000 |
News Archive
The fight against fake medicines could soon be aided by a small, portable device that quickly measures the hardness of a tablet, revealing whether it is counterfeit, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.
Brazilian researchers aim to determine the emergence and spread of the Delta VOC in different regions in Brazil.
SuperGen, Inc., a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that Eisai Inc. today released information regarding a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection in elderly patients with acute myeloid leukemia (AML). The comparator in this trial was low-dose cytarabine, a chemotherapy agent, or supportive care.
Earlier today, Anthem Blue Cross agreed to a request by the California Department of Insurance to postpone a rate adjustment for individual members in California by two months to allow the Department additional time for review. To avoid confusion for our members, this delay will impact all Anthem individual members regulated at either the state Department of Insurance or the Department of Managed Health Care.
› Verified 9 days ago
Dr. Tyler Robin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1665 Aurora Ct, Suite 1032, Msf706, Aurora, CO 80045 Phone: 720-848-0100 | |
Dr. Ryan Michael Lanning, M.D., PHD. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1665 Aurora Ct, Suite 1032, Aurora, CO 80045 Phone: 720-848-0100 Fax: 720-848-0113 | |
Stephanie C Hsu, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Thomas Suby-long, MD Radiology Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Alan E Evans, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Ajay Agarwal, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Eugene E Bourne, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 6428 S Blackhawk Way, Aurora, CO 80016 Phone: 720-870-5109 |